Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-21 1:01 pm Sale |
2025-01-17 | 13G | China SXT Pharmaceuticals, Inc. SXTC |
Streeterville Capital LLC | 0 0.000% |
-405,837 (Position Closed) |
Filing History |
| 2024-10-25 12:19 pm Purchase |
2024-10-25 | 13G | China SXT Pharmaceuticals, Inc. SXTC |
Streeterville Capital LLC | 405,837 9.990% |
405,837 (New Position) |
Filing History |
| 2024-08-15 09:45 am Sale |
2024-08-07 | 13G | China SXT Pharmaceuticals, Inc. SXTC |
Forsakringsaktiebolaget Avanza Pension | 45 1.290% |
-30,634 (-99.85%) |
Filing History |
| 2024-05-31 10:36 am Purchase |
2024-05-30 | 13G | China SXT Pharmaceuticals, Inc. SXTC |
Forsakringsaktiebolaget Avanza Pension | 30,679 5.420% |
17,242 (+128.32%) |
Filing History |
| 2024-02-09 10:14 am Sale |
2024-02-08 | 13G | China SXT Pharmaceuticals, Inc. SXTC |
Forsakringsaktiebolaget Avanza Pension | 13,437 2.380% |
-15,243 (-53.15%) |
Filing History |
| 2024-02-09 06:36 am Purchase |
2024-02-06 | 13G | China SXT Pharmaceuticals, Inc. SXTC |
Forsakringsaktiebolaget Avanza Pension | 28,680 5.070% |
28,680 (New Position) |
Filing History |
| 2023-03-29 2:19 pm Purchase |
2023-03-29 | 13G | China SXT Pharmaceuticals, Inc. SXTC |
Streeterville Capital LLC | 41,743 9.990% |
41,743 (New Position) |
Filing History |
| 2023-03-29 1:48 pm Sale |
2023-03-29 | 13G | China SXT Pharmaceuticals, Inc. SXTC |
Streeterville Capital LLC | 0 0.000% |
-8,117 (Position Closed) |
Filing History |
| 2023-02-13 4:28 pm Unchanged |
2022-12-31 | 13G | China SXT Pharmaceuticals, Inc. SXTC |
Lind Global Fund II LP | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2023-01-30 4:05 pm Purchase |
2022-10-07 | 13D | China SXT Pharmaceuticals, Inc. SXTC |
Zhou Albert Feng | 69,282 21.498% |
69,282 (New Position) |
Filing History |
| 2022-08-25 3:57 pm Purchase |
2022-08-25 | 13G | China SXT Pharmaceuticals, Inc. SXTC |
Streeterville Capital LLC | 8,117 9.990% |
8,117 (New Position) |
Filing History |
| 2022-01-21 5:01 pm Purchase |
2022-01-20 | 13G | China SXT Pharmaceuticals, Inc. SXTC |
Lind Global Fund II LP | 5,150 9.900% |
5,150 (New Position) |
Filing History |
| 2021-02-16 1:47 pm Sale |
2020-12-31 | 13G | China SXT Pharmaceuticals, Inc. SXTC |
Ayrton Capital LLC | 149 0.400% |
-1,185 (-88.82%) |
Filing History |
| 2021-02-10 5:45 pm Sale |
2020-12-31 | 13G | China SXT Pharmaceuticals, Inc. SXTC |
Hudson Bay Capital Management LP | 149 0.480% |
-1,222 (-89.12%) |
Filing History |